Relief Therapeutics (RLFTF) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free RLFTF Stock Alerts $1.45 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRelief Therapeutics (OTCMKTS:RLFTF) Trading Down 9%americanbankingnews.com - April 16 at 1:52 AMRelief Therapeutics Holding SA (RLFTF)ca.finance.yahoo.com - March 5 at 7:58 AMRelief Therapeutics Announces CEO Transitionfinance.yahoo.com - November 22 at 9:46 AMRelief Therapeutics Holding SA RLFTFmorningstar.com - November 15 at 7:38 PMRelief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestonefinance.yahoo.com - October 10 at 8:22 AMRelief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 1 at 3:25 AMRelief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeuticsfinance.yahoo.com - August 30 at 6:27 PMRelief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Healthfinanznachrichten.de - July 19 at 3:16 AMRelief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Healthfinance.yahoo.com - July 19 at 3:16 AMRelief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE(R) in the Middle Eastfinance.yahoo.com - June 23 at 7:49 AMRELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placementuk.sports.yahoo.com - June 23 at 1:16 AMRELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholdersfinance.yahoo.com - June 20 at 10:26 AMRELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholdersfinance.yahoo.com - June 20 at 10:26 AMRelief Therapeutics announces CHF 5M private placementmsn.com - June 16 at 9:56 AMRELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placementfinance.yahoo.com - June 16 at 9:56 AMRelief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratoryfinance.yahoo.com - May 15 at 1:49 AMRelief Therapeutics Has Filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange Commissionfinance.yahoo.com - May 12 at 10:47 PMRelief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Sharesfinance.yahoo.com - May 3 at 8:06 AMRelief Therapeutics Announces Executive Leadership Team Changefinance.yahoo.com - April 5 at 1:49 AMRelief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholdersfinance.yahoo.com - April 4 at 10:47 AMRelief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Boardmarkets.businessinsider.com - April 3 at 1:22 AMRelief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023finance.yahoo.com - March 22 at 2:58 AMRelief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meetingfinance.yahoo.com - March 17 at 7:50 PMRelief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europefinance.yahoo.com - March 16 at 8:40 AMRelief Therapeutics Provides Update From Collaboration Partner on OLPRUVAfinance.yahoo.com - March 15 at 9:52 AMRelief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosafinance.yahoo.com - February 14 at 10:00 AMRelief pulls Nasdaq IPO filing of ADSs with aim to list ordinary shares on exchangemsn.com - February 8 at 6:48 AMRelief Therapeutics Provides an Update on its Financing Strategyfinance.yahoo.com - February 8 at 6:48 AMRelief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphomfinance.yahoo.com - January 17 at 8:56 AMAcer wins FDA OK for Olpruva to treat urea cycle disordersseekingalpha.com - December 23 at 7:28 PMSwiss drug developer Relief Therapeutics upsizes proposed offering to $25Mmsn.com - December 23 at 7:28 PMRelief Therapeutics Announces Issuance of Shares from Authorized Capitalfinance.yahoo.com - December 13 at 2:16 AMRelief Therapeutics Announces Executive Leadership Team Changesfinance.yahoo.com - December 8 at 2:18 AMAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festivalfinance.yahoo.com - November 21 at 5:36 AMAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festivalfinance.yahoo.com - November 21 at 5:36 AMRelief, NRx reach settlement over COVID-19 therapy aviptadilseekingalpha.com - November 14 at 7:54 AMRelief Therapeutics Holding SA and NRx Pharmaceuticals, inc. Further Extend their Stay of Pending Litigation to Provide Additional Time for the Parties to Finalize their Litigation Settlementfinance.yahoo.com - November 8 at 3:34 AMRelief reports stability data on new formulation of lung disease drug RLF-100seekingalpha.com - November 7 at 6:18 AMRELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. Extend Their Stay of Pending Litigation to Provide Additional Time for The Parties to Finalize Their Settlementfinance.yahoo.com - October 26 at 2:28 AMRelief Announces U.S. Launch of PKU GOLIKEfinance.yahoo.com - October 10 at 7:45 AMRelief Announces Exclusive Distributor for PKU GOLIKE in the U.S.finance.yahoo.com - October 6 at 3:16 AMAcer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoatefinance.yahoo.com - October 3 at 10:35 AMRelief says Nexodyn's trial for rare skin disorder gets IRB approvalseekingalpha.com - September 22 at 7:27 AMRelief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicagofinance.yahoo.com - September 22 at 2:27 AMRelief Therapeutics Files Registration Statement on form F-1 with the U.S. Securities and Exchange Commissionfinance.yahoo.com - August 24 at 2:26 AMSwiss biotech Relief Therapeutics files for Nasdaq uplisting, $20M offeringseekingalpha.com - August 23 at 9:25 PMRelief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Tentative Settlement of Pending Litigationfinance.yahoo.com - August 22 at 1:54 AMRelief Therapeutics Appoints David McCullough as Head of U.S. Market Accessfinance.yahoo.com - August 17 at 4:32 AMRelief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100® (Aviptadil)markets.businessinsider.com - August 3 at 2:04 AMRelief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100(R) (Aviptadil)finance.yahoo.com - August 3 at 2:04 AM Get Relief Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLFTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here RLFTF Media Mentions By Week RLFTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RLFTF News Sentiment▼0.000.44▲Average Medical News Sentiment RLFTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RLFTF Articles This Week▼00▲RLFTF Articles Average Week Get Relief Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLFTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AWKNF News AXIM News BRRGF News BCTXW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RLFTF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relief Therapeutics Holding SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
